Applicant, as named in the Orange Book
Ardelyx Inc
Next listed expiry: Ibsrela on 26 Nov 2042. 2 products with live protection, 0 without.
Products with listed protection
| Drug | Earliest generic entry |
|---|---|
| Ibsrela NDA 211801 tenapanor hydrochloride | 26 Nov 2042 patent |
| Xphozah NDA 213931 ยท 2 strengths tenapanor hydrochloride | 26 Nov 2042 patent |
Recent events
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.